The QPIs have been developed collaboratively with the three Regional Cancer Networks (NCA, SCAN, WOSCAN), Public Health Scotland, and Healthcare Improvement Scotland. The aim is to improve survival and patient experience whilst reducing variance and ensuring safe, effective and person-centred cancer care. The Quality Performance Indicators (QPIs) for mesothelioma are new and this is the first time Mesothelioma has been audited separately in Scotland.
Analysis of these QPIs is essential in improving and driving continuous improvement in Mesothelioma care
QPI 1 – Diagnostic Imaging
(i) Proportion of patients in whom CT scan optimised for pleural assessment (between 60 and 90 seconds) is carried out for first discussion at the National MDT
(ii) Proportion of patients in whom CT scan optimised for pleural assessment (between 60 and 90 seconds) is carried out for first discussion at the National MDT and TNM stage is recorded
QPI 2 – Diagnostic Histopathology
(i) Proportion of patients with mesothelioma who have a histopathological diagnosis
(ii) Proportion of patients with a histopathological diagnosis of mesothelioma who have a subtype identified
(iii) Proportion of patients with a histopathological diagnosis of epthelioid who have IHC marks profiling undertaken
QPI 3 – Multidisciplinary Team
Proportion of patients with mesothelioma who are discussed at the national mesothelioma MDT meeting
QPI 4 – Systemtic Anti Cancer Treatment
Proportion of patients with mesothelioma and performance status (PS) 0-1 who receive first line treatment with SACT using Platinum and Pemetrexed
QPI 5 – Radiotherapy for Management of Pain
Proportion of patients with mesothelioma who are referred to the national MDT for pain relief who receive radiotherapy
QPI 6 – Pleural Fluid Management
Proportion of patients with mesothelioma with symptomatic pleural effusion who undergo either talc pleurodesis or indwelling pleural catheter (IPC) insertion to manage fluid
QPI 7 – Clinical Trial and Research Study Access
Proportion of patients with mesothelioma who are consented for a clinical trial/research study
QPI 8 – Post Mortem Examination
Proportion of patients who have died with a pathological diagnosis of mesothelioma who undergo post-mortem examination
Please here click to view our current QPI report and to access previous reports.